Antiviral activity, pharmacokinetics and safety of the second-generation hepatitis B core inhibitor ABI-H2158 in Phase 1b study of patients with HBeAg-positive chronic hepatitis B infection

2020 ◽  
Vol 73 ◽  
pp. S125
Author(s):  
Kosh Agarwal ◽  
Junqi Niu ◽  
Yanhua Ding ◽  
Edward Gane ◽  
Tuan Nguyen ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Antiviral Activity ◽  
Chronic Hepatitis B ◽  
Second Generation ◽  
Hepatitis B Infection ◽  
Chronic Hepatitis B Infection ◽  
Positive Chronic Hepatitis ◽  
Phase 1B

Serum HBV RNA level monitoring for response prediction in HBeAg positive chronic hepatitis B infection

2017 ◽  
Vol 66 (1) ◽  
pp. S479-S480
Author(s):  
M.J. van Campenhout ◽  
F. van Bömmel ◽  
M. Grossmann ◽  
J.J. Fischer ◽  
D. Deichsel ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Response Prediction ◽  
Hepatitis B Infection ◽  
Chronic Hepatitis B Infection ◽  
Positive Chronic Hepatitis ◽  
Level Monitoring

Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: A two-year study

2005 ◽  
Vol 43 (1) ◽  
pp. 60-66 ◽  
Author(s):  
Robert G. Gish ◽  
Huy Trinh ◽  
Nancy Leung ◽  
Francis K.L. Chan ◽  
Michael W. Fried ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Antiviral Activity ◽  
Chronic Hepatitis B ◽  
Hepatitis B Infection ◽  
Chronic Hepatitis B Infection
Sign in / Sign up

Export Citation Format

Share Document